At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
UroLift System proceduredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Median Lobe Prostatic UroLift Procedure
In Brief
A clinical study evaluating UroLift System procedure for Benign Prostatic Hyperplasia (BPH). Completed, enrolled 45 participants.
Detailed Summary
The purpose of this study is to evaluate the safety and effectiveness of using UroLift in subjects with a prostatic median lobe enlargement due to benign prostatic hyperplasia (BPH).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia (BPH)
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartFeb 2016
Primary CompletionMay 2017
Study CompletionDec 2017
TodayJul 2026
First PostedDec 9, 2015
Enrollment StartFeb 17, 2016
Primary CompletionMay 30, 2017
Study CompletionDec 19, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.6 years ago
Interventions
UroLift System proceduredevice
Minimally invasive procedure for treatment of lower urinary tract symptoms (LUTS) due to BPH